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Abstract: Oxidative stress induced by reactive oxygen species plays an important role in 
the etiology of many diseases. Dietary phytochemical products, such as bioactive food 
components and marine carotenoids (asthaxantin, lutein, β-carotene, fucoxanthin), have 
shown an antioxidant effect in reducing oxidative markers stress. Scientific evidence 
supports the beneficial role of phytochemicals in the prevention of some chronic diseases. 
Many carotenoids with high antioxidant properties have shown a reduction in disease risk 
both in epidemiological studies and supplementation human trials. However, controlled 
clinical trials and dietary intervention studies using well-defined subjects population have 
not provided clear evidence of these substances in the prevention of diseases. The most 
important aspects of this special issue will cover the synthesis, biological activities, and 
clinical applications of marine carotenoids, with particular attention to recent 
evidence  regarding anti-oxidant and anti-inflammatory properties in the prevention of 
cardiovascular disease. 
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Introduction 
Oxidative stress (OS) and chronic inflammation are the major pathophysiological factors 
contributing to the development of cardiovascular diseases (CVD), such as hypertension, diabetes and 
atherosclerosis. Accumulating evidence suggests that a compromised antioxidant system can lead to 
excessive OS in cardiovascular related organs, resulting in cell damage and death [1]. 
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Emerging evidence suggests that interventions, including nutrition, pharmacology, and physical 
exercise, may activate expression of cellular anti-oxidant systems and play a role in preventing 
inflammatory processes in CVD [2]. For these reasons new effective interventions, based on nutrition, 
aimed at targeting OS and chronic inflammation, may induce an important protection from CVD [3,4]. 
Advances in pathophysiological research suggest that CVD represent a continuum  of 
pathophysiological processes that advance from local redox imbalance to endothelial dysfunction, 
endothelial inflammation, and excessive vascular remodeling. Consequent cell damage contributes to 
atherosclerosis, coronary artery disease (CAD), stroke and myocardial infarction [5,6]. In particular 
CVD are associated with increased production of reactive oxygen species (ROS) and compromised 
endogenous anti-oxidant defense systems (superoxide dismutases (SODs), heme oxygenase-1 (HO-1), 
NAD(P)H quinone oxidoreductase-1 (NQO-1), catalase, and thioredoxin). OS is tightly regulated by a 
balance between production and removal of ROS. A compromised anti-oxidant defense system can 
lead to excessive oxidative stress and ultimately result in cell damage [7].  
The nutritional prevention of atherosclerosis with the use of natural antioxidants represents an 
important new frontier in the prevention and treatment of CVD. There is evidence that the production 
of oxidized LDL (LDLOX) can be counteracted by the activity of dietary free radical electron 
(“antioxidant”) acceptor molecules (such as β-carotene and ascorbic acid), which sequester free radical 
electrons and prevent the oxidation of LDL particles [8]. Many foods typical of the Mediterranean Diet 
(such as olive oil, red wine, fruits, and vegetables) contain a mixture of phytonutrients that are both 
water-soluble and lipid-soluble and can enhance antioxidant capacity throughout the organism, and 
variations of that dietary regimen are even more effective. For example, several naturally-occurring 
phytochemicals with antioxidant actions have been associated with the prevention of atherosclerosis, 
including the carotenoids, lycopene, lutein and astaxanthin, and glabridin, the major isoflavan obtained 
from licorice roots, even if this evidence is derived from studies presenting an important limitation due 
to the small number of subjects [9]. 
Although a large body of research has focused on individual or small numbers of antioxidants, 
increasing circulating antioxidant capacity through increased consumption of antioxidant-rich fruits 
and vegetables is protective against cardiovascular disease. The available scientific evidence indicates 
that the link between oxidative stress, a proinflammatory systemic environment and cardiovascular 
disease is strong [10]. This conclusion can provide increased motivation for dietary improvements that 
shift the risk equation away from premature death and toward increased longevity and enhanced 
quality of life. 
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